1,2-NAPHTHOQUINONE BASED DERIVATIVE AND METHOD OF PREPARING THE SAME

Disclosed are compounds represented by Formula (3) or (4), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof. Also disclosed are methods of preparing the same, and a pharmaceutical composition, which can be use...

Full description

Saved in:
Bibliographic Details
Main Authors LEE, MI JUNG, ROH, TAE CHEUL, LEE, YOU-HUI, KWAK, TAE HWAN, LEE, WHEE SEONG, KIM, BO JUNG, LEE, SEUNG HOON, LEE, KYU DAE
Format Patent
LanguageEnglish
French
Published 22.11.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are compounds represented by Formula (3) or (4), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof. Also disclosed are methods of preparing the same, and a pharmaceutical composition, which can be used for treatment or prevention of metabolic syndromes. La présente invention concerne un composé représenté par la formule chimique (1), un sel pharmaceutiquement acceptable de ce dernier, un hydrate, un solvate, un pro-médicament, un tautomère, un énantiomère, ou un diastéréomère pharmaceutiquement acceptable, un procédé de préparation associé, et une composition pharmaceutique le contenant et présentant des effets permettant le traitement ou la prévention de maladies métaboliques. La formule chimique (1) est la même que celle définie dans la revendication 1.
Bibliography:Application Number: CA20142935317